PubIndex
Search
Leaderboards
Bookmark
My Library
Sign in
Back
Agilent/Dako
PD-L1 IHC 22C3 pharmDx for Autostainer Link 48
#SK006 · western blot
59
Citing papers
1.5k
Combined citations
Copy product info
Export PDF dossier
Supplier page
Find this product
Research areas
Cancer Immunotherapy and Biomarkers
35
Immunotherapy and Immune Responses
10
CAR-T cell therapy research
8
Immune Cell Function and Interaction
7
Cancer Genomics and Diagnostics
6
Lung Cancer Treatments and Mutations
6
Ferroptosis and cancer prognosis
4
Inflammatory Biomarkers in Disease Prognosis
4
Papers citing this product
1
Renal tubule Cpt1a overexpression protects from kidney fibrosis by restoring mitochondrial homeostasis
Journal of Clinical Investigation
·
2021
·
329 cit.
·
DOI
2
Early Phase I Study of a <sup>99m</sup>Tc-Labeled Anti–Programmed Death Ligand-1 (PD-L1) Single-Domain Antibody in SPECT/CT Assessment of PD-L1 Expression in Non–Small Cell Lung Cancer
Journal of Nuclear Medicine
·
2019
·
162 cit.
·
DOI
3
Mapping the binding sites of antibodies utilized in programmed cell death ligand-1 predictive immunohistochemical assays for use with immuno-oncology therapies
Modern Pathology
·
2019
·
87 cit.
·
DOI
4
Abemaciclib in combination with pembrolizumab for HR+, HER2− metastatic breast cancer: Phase 1b study
npj Breast Cancer
·
2022
·
81 cit.
·
DOI
5
Quantitative assessment of PD-L1 as an analyte in immunohistochemistry diagnostic assays using a standardized cell line tissue microarray
Laboratory Investigation
·
2019
·
66 cit.
·
DOI
6
Intratumorally injected pro-inflammatory allogeneic dendritic cells as immune enhancers: a first-in-human study in unfavourable risk patients with metastatic renal cell carcinoma
Journal for ImmunoTherapy of Cancer
·
2017
·
59 cit.
·
DOI
7
Macrophages in Oral Carcinomas: Relationship with Cancer Stem Cell Markers and PD-L1 Expression
Cancers
·
2020
·
51 cit.
·
DOI
8
Cold and heterogeneous T cell repertoire is associated with copy number aberrations and loss of immune genes in small-cell lung cancer
Nature Communications
·
2021
·
50 cit.
·
DOI
9
Soluble PD-L1 works as a decoy in lung cancer immunotherapy via alternative polyadenylation
JCI Insight
·
2021
·
47 cit.
·
DOI
10
CLDN18.2 expression and its impact on prognosis and the immune microenvironment in gastric cancer
BMC Gastroenterology
·
2023
·
46 cit.
·
DOI
Show 49 more papers
Feedback
PD-L1 IHC 22C3 pharmDx for Autostainer Link 48 — Evidence — PubIndex